Published in Acta Oncol on January 01, 2001
Preoperative radiotherapy combined with total mesorectal excision for resectable rectal cancer. N Engl J Med (2001) 13.75
Improved survival with preoperative radiotherapy in resectable rectal cancer. Swedish Rectal Cancer Trial. N Engl J Med (1997) 9.99
ESMO Consensus Guidelines for management of patients with colon and rectal cancer. a personalized approach to clinical decision making. Ann Oncol (2012) 5.32
Sexually transmitted infection as a cause of anal cancer. N Engl J Med (1997) 4.05
Clinical determinants of survival in patients with 5-fluorouracil-based treatment for metastatic colorectal cancer: results of a multivariate analysis of 3825 patients. Ann Oncol (2002) 3.91
Evidence of an association between non-Hodgkin's lymphoma and skin cancer. BMJ (1995) 3.30
Cancer risk following organ transplantation: a nationwide cohort study in Sweden. Br J Cancer (2003) 2.64
Indications for allogeneic stem cell transplantation in chronic lymphocytic leukemia: the EBMT transplant consensus. Leukemia (2006) 2.38
Preoperative irradiation affects functional results after surgery for rectal cancer: results from a randomized study. Dis Colon Rectum (1998) 2.09
Second cancers among long-term survivors of Hodgkin's disease diagnosed in childhood and adolescence. J Clin Oncol (2000) 2.09
ESMO Guidelines consensus conference on malignant lymphoma 2011 part 1: diffuse large B-cell lymphoma (DLBCL), follicular lymphoma (FL) and chronic lymphocytic leukemia (CLL). Ann Oncol (2012) 2.03
Sunlight and non-Hodgkin's lymphoma: a population-based cohort study in Sweden. Int J Cancer (1999) 1.97
Initial or delayed chemotherapy with best supportive care in advanced gastric cancer. Ann Oncol (1994) 1.96
Pre- or postoperative radiotherapy in rectal and rectosigmoid carcinoma. Report from a randomized multicenter trial. Ann Surg (1990) 1.93
Combination of surgery and chemotherapy and the role of targeted agents in the treatment of patients with colorectal liver metastases: recommendations from an expert panel. Ann Oncol (2009) 1.93
Specific binding of proinsulin C-peptide to human cell membranes. Proc Natl Acad Sci U S A (1999) 1.91
Late gastrointestinal disorders after rectal cancer surgery with and without preoperative radiation therapy. Br J Surg (2008) 1.87
Preoperative or postoperative irradiation in adenocarcinoma of the rectum: final treatment results of a randomized trial and an evaluation of late secondary effects. Dis Colon Rectum (1993) 1.87
Early prediction of response to first-line chemotherapy by sequential [18F]-2-fluoro-2-deoxy-D-glucose positron emission tomography in patients with advanced colorectal cancer. Ann Oncol (2009) 1.77
Malignant lymphomas in coeliac disease: evidence of increased risks for lymphoma types other than enteropathy-type T cell lymphoma. Gut (2005) 1.75
Bladder and kidney cancer following cyclophosphamide therapy for non-Hodgkin's lymphoma. J Natl Cancer Inst (1995) 1.74
Adjuvant treatment of colorectal cancer (current expert opinion derived from the Third International Conference: Perspectives in Colorectal Cancer, Dublin, 2001). Eur J Cancer (2002) 1.66
Variants of squamous cell carcinoma of the anal canal and perianal skin and their relation to human papillomaviruses. Cancer Res (1999) 1.63
A systematic overview of chemotherapy effects in colorectal cancer. Acta Oncol (2001) 1.61
Cellular immune reconstitution after subcutaneous alemtuzumab (anti-CD52 monoclonal antibody, CAMPATH-1H) treatment as first-line therapy for B-cell chronic lymphocytic leukaemia. Leukemia (2004) 1.60
Prognostic significance of the microvascular count in colorectal cancer. J Clin Oncol (1996) 1.59
Cytoreductive surgery and intraperitoneal chemotherapy for colorectal peritoneal carcinomatosis: prognosis and treatment of recurrences in a cohort study. Eur J Surg Oncol (2012) 1.58
Impaired postoperative leucocyte counts after preoperative radiotherapy for rectal cancer in the Stockholm III Trial. Br J Surg (2013) 1.56
Systemic exposure of the parent drug oxaliplatin during hyperthermic intraperitoneal perfusion. Eur J Clin Pharmacol (2008) 1.56
Standard-dose anti-CD20 antibody rituximab has efficacy in chronic lymphocytic leukaemia: results from a Nordic multicentre study. Eur J Haematol (2002) 1.55
Radiological findings do not support lateral residual tumour as a major cause of local recurrence of rectal cancer. Br J Surg (2006) 1.54
Lung cancer after treatment for Hodgkin's disease: focus on radiation effects. Radiat Res (2003) 1.54
Model describing the relationship between pharmacokinetics and hematologic toxicity of the epirubicin-docetaxel regimen in breast cancer patients. J Clin Oncol (2004) 1.51
Anorectal malignant melanoma in Sweden. Report of 49 patients. Dis Colon Rectum (1990) 1.50
Efficacy of 5-fluorouracil-based chemotherapy in elderly patients with metastatic colorectal cancer: a pooled analysis of clinical trials. Ann Oncol (2004) 1.49
A systematic overview of chemotherapy effects in gastric cancer. Acta Oncol (2001) 1.46
Relationship between age and survival in cancer of the colon and rectum with special reference to patients less than 40 years of age. Br J Surg (1990) 1.45
The management of pancreatic cancer. Current expert opinion and recommendations derived from the 8th World Congress on Gastrointestinal Cancer, Barcelona, 2006. Ann Oncol (2007) 1.44
Colorectal cancer with and without microsatellite instability involves different genes. Genes Chromosomes Cancer (1999) 1.44
Heparan sulfate proteoglycan of cultured cells: demonstration of a lipid- and a matrix-associated form. Biochem Biophys Res Commun (1981) 1.44
Sensitivity and specificity of CA242 in gastro-intestinal cancer. A comparison with CEA, CA50 and CA 19-9. Br J Cancer (1992) 1.39
Preoperative short-course radiotherapy with delayed surgery in primary rectal cancer. Br J Surg (2012) 1.37
Laboratory determination of chemotherapeutic drug resistance in tumor cells from patients with leukemia, using a fluorometric microculture cytotoxicity assay (FMCA). Int J Cancer (1992) 1.37
A systematic overview of chemotherapy effects in breast cancer. Acta Oncol (2001) 1.36
Microsatellite instability in sporadic colorectal cancer is not an independent prognostic factor. Br J Cancer (1999) 1.36
Second cancers among long-term survivors of non-Hodgkin's lymphoma. J Natl Cancer Inst (1993) 1.34
The initial change in tumor size predicts response and survival in patients with metastatic colorectal cancer treated with combination chemotherapy. Ann Oncol (2011) 1.33
Interim analysis of the Stockholm III trial of preoperative radiotherapy regimens for rectal cancer. Br J Surg (2010) 1.31
Treatment of the elderly colorectal cancer patient: SIOG expert recommendations. Ann Oncol (2008) 1.29
Analysis of oligonucleotide probe affinities using surface plasmon resonance: a means for mutational scanning. Anal Biochem (1997) 1.24
Maternal and perinatal risk factors for childhood brain tumors (Sweden). Cancer Causes Control (1996) 1.24
Improved survival in cancer of the colon and rectum in Sweden. Eur J Surg Oncol (2005) 1.21
Extended rituximab therapy in Waldenström's macroglobulinemia. Ann Oncol (2005) 1.20
Prognostic value of p53 genetic changes in colorectal cancer. J Clin Oncol (1999) 1.20
Local recurrences after surgical treatment for rectal carcinoma. Acta Chir Scand (1984) 1.19
Improved survival in patients with peritoneal metastases from colorectal cancer: a preliminary study. Br J Cancer (2004) 1.17
Growth differentiation factor 15: a prognostic marker for recurrence in colorectal cancer. Br J Cancer (2011) 1.16
Population pharmacokinetic modelling of unbound and total plasma concentrations of paclitaxel in cancer patients. Eur J Cancer (2003) 1.16
Effect of a platelet endoglycosidase on cell surface associated heparan sulphate of human culturei endothelial and glial cells. Thromb Res (1977) 1.15
Composition and distribution of glycosaminoglycans in cultures of human normal and malignant glial cells. Biochem J (1978) 1.15
Improved survival and reduction in local failure rates after preoperative radiotherapy: evidence for the generalizability of the results of Swedish Rectal Cancer Trial. Ann Surg (1999) 1.15
Improved survival of patients with cancers of the colon and rectum? J Natl Cancer Inst (1988) 1.15
Demonstration of an extracellular matrix in multicellular tumor spheroids. Cancer Res (1984) 1.14
Prognostic predictors in colorectal cancer. Dis Colon Rectum (1994) 1.13
Tobacco smoking as a risk factor in anal carcinoma: an antiestrogenic mechanism? J Natl Cancer Inst (1999) 1.13
Predicting anxiety and depression among cancer patients: a clinical model. Eur J Cancer (2001) 1.13
Binding of heparin on the surface of cultured human endothelial cells. Thromb Res (1978) 1.12
Changing strategy for rectal cancer is associated with improved outcome. Br J Surg (1999) 1.11
The role of the general practitioner in cancer care and the effect of an extended information routine. Scand J Prim Health Care (2000) 1.11
Hope for a cure and altruism are the main motives behind participation in phase 3 clinical cancer trials. Eur J Cancer Care (Engl) (2014) 1.11
High expression of tumour-associated trypsin inhibitor correlates with liver metastasis and poor prognosis in colorectal cancer. Br J Cancer (2009) 1.11
The risk of subsequent primary malignant diseases after cancers of the colon and rectum. A nationwide cohort study. Cancer (1990) 1.10
Incidence of anal epidermoid carcinoma in Sweden 1970-1984. Acta Chir Scand (1989) 1.10
Improved survival in patients with rectal cancer: a population-based register study. Br J Surg (1998) 1.10
A chondroitin sulphate proteoglycan from human cultured glial cells aggregates with hyaluronic acid. Biochem Biophys Res Commun (1978) 1.09
The potential for improved outcome in patients with hepatic metastases from colon cancer: a population-based study. Eur J Surg Oncol (2004) 1.09
Late adverse effects of short-course preoperative radiotherapy in rectal cancer. Br J Surg (2006) 1.08
Patient characteristics and stratification in medical treatment studies for metastatic colorectal cancer: a proposal for standardization of patient characteristic reporting and stratification. Ann Oncol (2007) 1.08
Complications after double and single stapling in rectal surgery. Eur J Surg (1991) 1.07
Influence of 5-fluorouracil and folinic acid on colonic healing: an experimental study in the rat. Br J Surg (1992) 1.07
Comparative treatment planning between proton and x-ray therapy in esophageal cancer. Int J Radiat Oncol Biol Phys (1998) 1.07
The influence of RBE variations in a clinical proton treatment plan for a hypopharynx cancer. Phys Med Biol (2005) 1.07
Dynamics of nonstructural carbohydrates and biomass yield in a fodder legume tree at different harvest intensities. Tree Physiol (2001) 1.07
Prognostic significance of flow cytometry studies in B-cell non-Hodgkin lymphoma. Hematol Oncol (1990) 1.05
Molecular changes in second primary lung and breast cancers after therapy for Hodgkin's disease. Cancer Epidemiol Biomarkers Prev (2000) 1.05
Lymphoma incidence in a Swedish county during 1969-1987. Acta Oncol (1992) 1.05
Implementation of pencil kernel and depth penetration algorithms for treatment planning of proton beams. Phys Med Biol (2000) 1.05
Identification of molecular mechanisms for cellular drug resistance by combining drug activity and gene expression profiles. Br J Cancer (2005) 1.05
Cancer staging and survival in colon cancer is dependent on the quality of the pathologists' specimen examination. Eur J Cancer (2005) 1.04